A Stochastic Model of the Interleukin (IL)-1β Network

  • Johnny Kelsey
  • Brian Henderson
  • Rob Seymour
  • Andy Hone
Part of the Lecture Notes in Computer Science book series (LNCS, volume 5132)


The interleukin-1β network is a primary mediator of the inflammatory response and plays an important role in many immunological processes. A Markov chain model of the network is presented, along with results from iteration over the stochastic matrix. The stationary distribution of the model is analysed.


IL-1β interleukin-1β Markov process cytokine network stochastic matrix 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Auron, P.E., et al.: Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. PNAS 81, 7907–7911 (1984)CrossRefGoogle Scholar
  2. 2.
    Auron, P.E.: The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor 9, 221–237 (1998)CrossRefGoogle Scholar
  3. 3.
    Bandman, O., et al.: Complexity of inflammatory responses in endothelial cells and vascular smooth muscle cells determined by microarray analysis. Ann. N.Y. Acad. Sci. 975, 77–90 (2002)CrossRefGoogle Scholar
  4. 4.
    Bensimon, C., et al.: A monoclonal antibody recognizing 68- to 75-kilodalton protein(s) associated with the human IL-1 receptor. J. Immunol. 142, 2290–2298 (1989)Google Scholar
  5. 5.
    Bensimon, C., et al.: Two distinct affinity binding sites for IL-1 on human cell lines. J. Immunol. 143, 1168–1174 (1989)Google Scholar
  6. 6.
    Horuk, R., et al.: A biochemical and kinetic analysis of the interleukin-1 receptor. Evidence for differences in molecular properties of IL-1 receptors. J. Biol. Chem. 262, 16275–16278 (1987)Google Scholar
  7. 7.
    Boraschi, D., et al.: Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains. J. Immunol. 155, 4719–4725 (1995)Google Scholar
  8. 8.
    Colotta, F., et al.: The type II decoy receptor: a novel regulatory pathway for interleukin 1. Immunol. Today 15, 562–566 (1994)CrossRefGoogle Scholar
  9. 9.
    Dinarello, C.A.: Biology of interleukin-1. J. FASEB, 108–115 (1988)Google Scholar
  10. 10.
    Dinarello, C.A.: Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16, 457–499 (1998)CrossRefGoogle Scholar
  11. 11.
    Eisenberg, S.P., et al.: Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc. Natl. Acad. Sci. U.S.A. 88, 5232–5236 (1991)CrossRefGoogle Scholar
  12. 12.
    Greenfeder, S.A., et al.: Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270, 13757–13765 (1995)CrossRefGoogle Scholar
  13. 13.
    Grimmett, G., Stirzaker, D.: Probability and random processes. Oxford University Press, Oxford (2001)Google Scholar
  14. 14.
    Jit, M., Henderson, B., Stevens, M., Seymour, R.: TNF-α neutralization in cytokine-driven diseases: a mathematical model to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome. Rheumatology 44, 323–331 (2005)CrossRefGoogle Scholar
  15. 15.
    Jurič, D.M., Čarman-Kržan, M.: Interleukin-1β, but not IL-1α, mediates nerve growth factor secretion from rat astrocytes via type I IL-1 receptor. Int. J. Dev. Neurosci. 19, 675–683 (2001)CrossRefGoogle Scholar
  16. 16.
    Matsushima, K., et al.: Properties of a specific IL-1 receptor on human EBV-transformed B lymphocytes: identity of the receptor for IL-1a and IL-1β. J. Immunol. 136, 4496–4502 (1986)Google Scholar
  17. 17.
    Park, T.: Non-Euclidean graphs. Publicationes mathematicae (Debrecen) 6, 290–297 (1959)MathSciNetGoogle Scholar
  18. 18.
    Poole, S., Gaines Das, R.E.: The international standards for interleukin 1α and interleukin 1β. Evaluation in an international collaborative study. J. Immunol. Methods 142, 1–13 (1991)CrossRefGoogle Scholar
  19. 19.
    Schotanus, K., et al.: Domains of rat interleukin 1 beta involved in type I receptor binding. Endocrinology 36, 332–339 (1995)CrossRefGoogle Scholar
  20. 20.
    Sims, J.E., Dower, S.K.: Interleukin-1 receptors. Eur. Cytokine Netw. 5, 539–546 (1994)Google Scholar
  21. 21.
    Smith, D., et al.: The Soluble Form of IL-1 Receptor Accessory Protein Enhances the Ability of Soluble Type II IL-1 Receptor to Inhibit IL-1 Action. Immunity 18, 87–96 (2003)CrossRefGoogle Scholar
  22. 22.
    Wesche, H., et al.: The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272, 7727–7731 (1997)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Johnny Kelsey
    • 1
  • Brian Henderson
    • 2
  • Rob Seymour
    • 3
  • Andy Hone
    • 4
  1. 1.CoMPLEXUniversity College London 
  2. 2.Division of Microbial DiseasesUniversity College London 
  3. 3.CoMPLEX/Department of MathematicsUniversity College London 
  4. 4.IMSASUniversity of Kent 

Personalised recommendations